These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18569844)

  • 41. Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis.
    Lukusa AK; Vermylen C
    Haematologica; 2008 Nov; 93(11):e67; discussion e68. PubMed ID: 18978293
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A generic approach for the determination of trace hydrazine in drug substances using in situ derivatization-headspace GC-MS.
    Sun M; Bai L; Liu DQ
    J Pharm Biomed Anal; 2009 Feb; 49(2):529-33. PubMed ID: 19097722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea.
    Couronné L; Schneider P; de Montalembert M; Dumesnil C; Lahary A; Vannier JP
    Ann Hematol; 2009 Jun; 88(6):597-8. PubMed ID: 18979099
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis.
    Vial J; Cohen M; Sassiat P; Thiébaut D
    Curr Med Res Opin; 2008 Jul; 24(7):2019-33. PubMed ID: 18544188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concerns about the safety of obesity agents from a manufacturing perspective.
    Kanfer I
    Postgrad Med; 2008 Jul; 120(2):42-5. PubMed ID: 18654067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydroxycarbamide and erythropoietin in the preoperative management of children with sickle cell anaemia undergoing moderate risk surgery.
    Furness CL; O'Driscoll S; Davenport M; Morrison G; Height SE; Dick MC; Rees DC
    Br J Haematol; 2009 Feb; 144(3):453-4. PubMed ID: 19036093
    [No Abstract]   [Full Text] [Related]  

  • 48. The protein science of biosimilars.
    Kuhlmann M; Covic A
    Nephrol Dial Transplant; 2006 Oct; 21 Suppl 5():v4-8. PubMed ID: 16959791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The multicomponent automated dissolution system: an alternative in the development and pharmaceutical analysis of generic polydrugs.
    Fuerte V; Maldonado M; Rees GD
    J Pharm Biomed Anal; 1999 Nov; 21(2):267-72. PubMed ID: 10703981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem).
    Leelarasamee A; Rongrungruang Y; Trakulsomboon S; Pongpech P; Thanawattanawanich P; Jithavech P
    J Med Assoc Thai; 2008 Jul; 91(7):980-8. PubMed ID: 18839835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxycarbamide in sickle cell syndrome: new drug. For severe cases only.
    Prescrire Int; 2009 Feb; 18(99):15. PubMed ID: 19388211
    [No Abstract]   [Full Text] [Related]  

  • 52. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advances in sickle cell disease].
    de Montalembert M
    Bull Acad Natl Med; 2008 Oct; 192(7):1375-81; discussion 1381. PubMed ID: 19445363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why EMA should provide clearer guidance on the authorization of NBCDs in generic and hybrid applications.
    Garattini L; Padula A
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):243-245. PubMed ID: 27997812
    [No Abstract]   [Full Text] [Related]  

  • 55. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antisickling activity of anthocyanins from Bombax pentadrum, Ficus capensis and Ziziphus mucronata: photodegradation effect.
    Mpiana PT; Mudogo V; Tshibangu DS; Kitwa EK; Kanangila AB; Lumbu JB; Ngbolua KN; Atibu EK; Kakule MK
    J Ethnopharmacol; 2008 Dec; 120(3):413-8. PubMed ID: 18930798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of ceftriaxone in Pakistan: reality and resonance.
    Obaid A
    Pak J Pharm Sci; 2009 Apr; 22(2):220-9. PubMed ID: 19339236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of generic medication in epilepsy: a review of potential issues and challenges.
    Van Paesschen W; Hauman H; Lagae L
    Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adverse events related to substitution of generic products in Norway 2005].
    Reppe LA; Stenberg-Nilsen H; Harg P; Hegge AB; Lillefloth AK; Buajordet I
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2696-700. PubMed ID: 19079413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New issues in adult sickle sell disease].
    Girot R; Stankovic K; Lionnet F
    Bull Acad Natl Med; 2008 Oct; 192(7):1395-409; discussion 1409-11. PubMed ID: 19445365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.